We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $5.12B
1-Year Est. Return 314.02%
This Fund
S&P 500
This Quarter Est. Return
-14.51%
1 Year Est. Return
+314.02%
3 Year Est. Return
+1,498.66%
5 Year Est. Return
+2,457.67%
10 Year Est. Return
+48,821.41%
AUM
$1.25B
AUM Growth
-$409M
Cap. Flow
-$35.9M
Cap. Flow %
-2.87%
Top 10 Hldgs %
50.14%
Holding
212
New
40
Increased
31
Reduced
43
Closed
54

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$43.5M
2
RGNX icon
Regenxbio
RGNX
+$19.9M
3
ARAV
Aravive, Inc. Common Stock
ARAV
+$15.6M
4
ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
+$14.2M
5
LJPC
La Jolla Pharmaceutical Company
LJPC
+$12.7M

Top Sells

Rank Stock Value
1
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$19M
2
AGN
Allergan plc
AGN
+$18M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$17.5M
4
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$17M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 77.95%
2 Consumer Discretionary 0.07%
3 Financials 0.04%
4 Energy 0.02%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRIS icon
126
Curis
CRIS
$9.71M
$202K 0.02%
+50
New +$283K
ELV icon
127
Elevance Health
ELV
$81.5B
$201K 0.02%
1,436
– –
MOH icon
128
Molina Healthcare
MOH
$10.4B
$199K 0.02%
2,888
– –
CAH icon
129
Cardinal Health
CAH
$53.7B
$198K 0.02%
2,574
– –
HCA icon
130
HCA Healthcare
HCA
$90.6B
$198K 0.02%
2,563
-48,000
-95% -$4.25M
CNCE
131
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$195K 0.02%
+10,379
New +$176K
PMC
132
DELISTED
PharMerica Corporation
PMC
$194K 0.02%
6,800
– –
GTS
133
DELISTED
Triple-S Management Corporation
GTS
$189K 0.02%
11,147
– –
MGLN
134
DELISTED
Magellan Health Services, Inc.
MGLN
$189K 0.02%
3,410
+510
+18% +$30.8K
WCG
135
DELISTED
Wellcare Health Plans, Inc.
WCG
$189K 0.02%
+2,189
New +$192K
ICLR icon
136
Icon
ICLR
$13.7B
$187K 0.01%
2,631
-717
-21% -$54K
CBM
137
DELISTED
Cambrex Corporation
CBM
$186K 0.01%
4,692
-2,639
-36% -$123K
LPNT
138
DELISTED
LifePoint Health, Inc.
LPNT
$179K 0.01%
+2,522
New +$205K
AMGN icon
139
Amgen
AMGN
$209B
$177K 0.01%
+1,280
New +$202K
INFI
140
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$169K 0.01%
20,000
-21,000
-51% -$194K
LCI
141
DELISTED
Lannett Company, Inc.
LCI
$168K 0.01%
+1,012
New +$222K
SCMP
142
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$157K 0.01%
+7,905
New +$181K
SCTL
143
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$145K 0.01%
+13,450
New +$171K
DVCR
144
DELISTED
Diversicare Healthcare Services Inc
DVCR
$127K 0.01%
12,337
-3,000
-20% -$34.4K
AMAG
145
DELISTED
AMAG Pharmaceuticals
AMAG
$115K 0.01%
+2,904
New +$180K
MYGN icon
146
Myriad Genetics
MYGN
$476M
$94K 0.01%
2,500
– –
ELGX
147
DELISTED
Endologix Inc
ELGX
$71K 0.01%
576
-31,224
-98% -$4.24M
NSPH
148
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$58K ﹤0.01%
35,379
– –
JNP
149
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$20K ﹤0.01%
1,736
-43,164
-96% -$477K
BHC icon
150
CALL
Bausch Health
BHC
$1.75B
$18K ﹤0.01%
+100
New +$23.3K
4 5
6
7 8

Similar funds

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Perceptive Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Perceptive Advisors held 212 positions worth $1.25B, down 25% from $1.66B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors's Q3 2015 filing shows 40 new, 31 increased, 43 reduced and 54 closed positions. Its largest new stake was Global Blood Therapeutics, Inc.: 921,800 shares worth $38.9M. The largest sale was ZS PHARMA INC COMS TK (DE), an estimated $19M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 77% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Perceptive Advisors's largest Q3 2015 buy was Global Blood Therapeutics, Inc.: 921,800 shares worth $38.9M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2015, an estimated $15.6M increase.
  • Perceptive Advisors's biggest Q3 2015 reduction was ANI Pharmaceuticals, cutting an estimated $17.5M.
  • Perceptive Advisors fully exited ZS PHARMA INC COMS TK (DE) in Q3 2015, selling an estimated $19M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.25B portfolio in Q3 2015.
  • Perceptive Advisors opened 40 new positions and closed 54 in Q3 2015.
  • Perceptive Advisors's portfolio value fell 25% quarter-over-quarter to $1.25B.

Based on Perceptive Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.